首页TCGGY • OTCMKTS
add
Tecan Group ADR
市场资讯
财务信息
损益表
收入
净收入
| (CHF) | 2024年6月info | 年同比变化 |
|---|---|---|
收入 | 2.34亿 | -13.73% |
经营支出 | 6743.55万 | -4.70% |
净收入 | 1123.00万 | -57.78% |
净利润率 | 4.81 | -51.02% |
每股收益 | — | — |
息税折旧摊销前利润 | 2646.05万 | -40.50% |
有效税率 | 20.45% | — |
资产负债表
总资产
负债总额
| (CHF) | 2024年6月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 3.44亿 | 10.13% |
总资产 | 21.16亿 | 1.85% |
负债总额 | 7.10亿 | -3.35% |
权益总额 | 14.06亿 | — |
发行在外的股份 | 1278.86万 | — |
市净率 | 0.76 | — |
资产回报率 | 1.53% | — |
资本回报率 | 1.89% | — |
现金流
现金净变动
| (CHF) | 2024年6月info | 年同比变化 |
|---|---|---|
净收入 | 1123.00万 | -57.78% |
来自运营的现金 | 2171.25万 | -47.34% |
投资现金 | -650.50万 | 51.81% |
融资现金 | -2889.75万 | -34.24% |
现金净变动 | -1234.25万 | -332.26% |
自由现金流 | 2338.08万 | -27.14% |
简介
Tecan Group Ltd. is a Swiss company providing laboratory instruments and solutions in biopharmaceuticals, forensics, clinical diagnostics and medical technology for pharmaceutical and biotechnology companies, university research departments, diagnostic laboratories and clinics.
The company specializes in laboratory automation. As an original equipment manufacturer, it develops and manufactures OEM instruments, components and medical devices that are then distributed by partner companies.
Founded in Switzerland, in 1980, the company has over 3,500 employees, owns production and research and development sites in both North America, Europe and APAC and maintains a sales and service network in 52 countries.
In 2021, Tecan generated sales of CHF 946 million. Registered shares of Tecan Group are traded on the SIX Swiss Exchange. Wikipedia
成立时间
1980
员工数量
3,000
